SEC Form 4 · accession 0001110783-17-000050
MONSANTO CO /NEW/ · MON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Mizell
Officer — EVP, Chief HR Officer
Period of report
Apr 10, 2017
Accepted (ET)
Apr 12, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001110783
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 10, 2017 | M | 6,584 | $90.48 | A | 50,295 | D | |
| Common Stock | Apr 10, 2017 | M | 7,116 | $91.34 | A | 57,411 | D | |
| Common StockF1 | Apr 10, 2017 | S | 13,700 | $116.113 | D | 43,711 | D | |
| Common Stock | holding | — | — | — | 1,004 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F2 | $90.48 | Apr 10, 2017 | M | 6,584 | D | Nov 15, 2013 | Oct 16, 2022 | Common Stock | 6,584 | 91 | D |
| Option (Right to Buy)F3 | $91.34 | Apr 10, 2017 | M | 7,116 | D | Nov 15, 2016 | Oct 26, 2025 | Common Stock | 7,116 | 14,234 | D |
Explanation of responses
- F1This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $116.10 to $116.20. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
- F2One-third of the options became exercisable on November 15, 2013, one-third of the options became exercisable on November 15, 2014 and the remainder of the options became exercisable on November 15, 2015, subject to the terms and conditions of the Monsanto Company 2005 Long Term Incentive Plan.
- F3One-third of the options became exercisable on November 15, 2016, one-third of the options become exercisable on November 15, 2017 and the remainder of the options become exercisable on November 15, 2018, subject to the terms and conditions of the Monsanto Company 2005 Long-Term Incentive Plan.